Companies that passed the preliminary listing review on KOSDAQ 3companies · paid-in capital increases · stake acquisitions disclosed
24On the day, on KOSDAQ, Hachitech, Nears Lab, and Skylabs passed the preliminary listing review, while April Bio decided on a KRW hundred-million-won-scale third-party allotment paid-in capital increase.1,420a KRW hundred-million-won-scale third-3party allotment paid-in capital increase. Celemics disclosed a KRW hundred-million-won-scale paid-in capital increase in C&P, while Ark Solutions disclosed that it would acquire 100KRW hundred-million-won-scale shares in SCL, 5 million shares (30KRW hundred million, a stake of 3.2%) respectively.

24On the day, disclosures on passing the preliminary listing review, paid-in capital increases, and stake acquisitions followed one after another on KOSDAQ.
The Korea Exchange's KOSDAQ Market Division said that, following deliberation and resolution by the Listing Committee on 24the day, it approved the preliminary listing review for Hachitech, Nears Lab, and Skylabs, among other 3companies.
KOSDAQ-listed April Bio (397030) disclosed that on 24the day it had decided on a third-party allotment paid-in capital increase for working capital and other purposes. The offering amount is 3KRW hundred million.1,420It is a KRW hundred-million-won-scale offering.
Selemix (331920) announced that it had decided on a rights offering allocated to C&P for the purpose of acquiring securities of another corporation and other uses,24for the purpose of acquiring securities of another corporation and other uses,3through a third-party allotment. The amount to be raised is100hundred million won.
Ark Solutions (203690) announced on the same day that it would acquire5ten thousand shares of SCL for30hundred million won. Following the acquisition, its ownership stake in SCL will be3.2%.
All disclosures were announced24dated respectively through exchange and company disclosures. Each disclosure specifies the purpose, amount, allocation method, or the number and price of shares acquired, among other details.
Investors need to check the new share issuance date, allottees, new share issue price, and future schedule in the individual disclosure documents.
Sources: 연합뉴스 경제
Bullstory synthesized this report from the linked sources. AI may have assisted the writing process. Check the original reports for factual confirmation.